<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (ACR) reflects urinary albumin excretion and is increasingly being accepted as an important clinical outcome predictor </plain></SENT>
<SENT sid="1" pm="."><plain>Because of the great public health need for a simple and inexpensive test to identify individuals at high risk for developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, it has been suggested that the ACR might serve this purpose </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore determined whether the ACR could predict incident <z:mp ids='MP_0002055'>diabetes</z:mp> in a well-characterized cohort of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">pre-diabetic</z:e> Americans </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 3,188 <z:mp ids='MP_0002055'>Diabetes</z:mp> Prevention Program (DPP) participants with a mean BMI of 34 kg/m(2) and elevated fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>, and baseline urinary albumin excretion measurements were followed for incident <z:mp ids='MP_0002055'>diabetes</z:mp> over a mean of 3.2 years </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the participants, 94% manifested ACR levels below the <z:mp ids='MP_0002959'>microalbuminuria</z:mp> range and 21% ultimately developed <z:mp ids='MP_0002055'>diabetes</z:mp> during follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>Quartiles of ACR (median [range] within quartiles: 1, 3.0 [0.7-3.7]; 2, 4.6 [3.7-5.5]; 3, 7.1 [5.5-9.7]; and 4, 16.5 [9.7-1,578]) were positively associated with age, markers of <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and insulin secretion and resistance, blood pressure, and use of <z:chebi fb="0" ids="35674">antihypertensive agents</z:chebi> with antiproteinuric effects and inversely related to male sex and serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>An elevated hazard rate for developing <z:mp ids='MP_0002055'>diabetes</z:mp> with doubling of ACR disappeared after adjustment for covariates </plain></SENT>
<SENT sid="7" pm="."><plain>Within the DPP intervention groups (placebo, lifestyle, and <z:chebi fb="0" ids="6801">metformin</z:chebi>), we found no consistent trend in incident <z:mp ids='MP_0002055'>diabetes</z:mp> by quartile or decile of ACR </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: An ACR at levels below the <z:mp ids='MP_0002959'>microalbuminuria</z:mp> range does not independently predict incident <z:mp ids='MP_0002055'>diabetes</z:mp> in adults at high risk of developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>